中国生化药物杂志2017,Vol.37Issue(3) :276-278.DOI:10.3969/j.issn.1005-1678.2017.03.086

枸橼酸莫沙必利片对胃食管反流病患者胃泌素的影响

Effect of mosxapride citrate on gastrin in patients with gastroesophageal reflux

李学琴 高建康
中国生化药物杂志2017,Vol.37Issue(3) :276-278.DOI:10.3969/j.issn.1005-1678.2017.03.086

枸橼酸莫沙必利片对胃食管反流病患者胃泌素的影响

Effect of mosxapride citrate on gastrin in patients with gastroesophageal reflux

李学琴 1高建康2
扫码查看

作者信息

  • 1. 山西省阳泉市第二人民医院内一科,山西阳泉045011
  • 2. 山西省阳泉市第一人民医院内分泌科,山西阳泉045000
  • 折叠

摘要

目的 研究枸橼酸莫沙必利片对胃食管反流病患者胃泌素的影响,并分析其临床疗效.方法 选取2013年8月~2016年8月山西省阳泉市第二人民医院收治的86例胃食管反流病患者,随机分为观察组和对照组,每组43例.对照组在基础治疗上使用埃索美拉唑进行治疗,观察组在对照组治疗基础上给予枸橼酸莫沙必利片进行治疗.分析2组患者临床疗效和不良反应,比较2组患者治疗前后视觉模拟评分(VAS)、胃泌素、胃动素变化.结果 治疗后,观察组总有效率显著高于对照组[90.70%(39/43)vs.65.12%(28/43)](P<0.05);观察组的VAS评分明显低于对照组[(2.43±0.25)vs.(4.02±0.41)](P<0.05);观察组胃泌素、胃动素水平显著高于对照组[(55.87±4.82)pg/mL、(308.43±19.31)pg/mL vs.(44.12±3.86)pg/mL、(243.12±15.76)pg/mL](P<0.05).2组不良反应发生率比较差异无统计学意义.结论 枸橼酸莫沙必利片治疗胃食管反流病患者临床疗效良好,能有效改善胃泌素水平和临床症状,且不良反应率低.

Abstract

Objective To study the effect of mosapride citrate in the treatment of gastroesophageal reflux disease and its effect on gastrin .Methods 86 patients with gastroesophageal reflux disease admitted in our hospital from August 2013 to August 2016, those patients were divided into observation group and control group according to the order of admission,43 cases in each group.The control group was treated with esomeprazole on the basis of basal therapy, and the observation group was treated with mosapride citrate on the basis of control group.The clinical curative effect and adverse reaction were analyzed,visual analogue scale(VAS), gastrin and motilin were compared before and after treatment between the two groups.Results After treatment, the total effective rate in the observation group was significantly higher than the control group [90.70% (39/43) vs.65.12% (28/43)](P<0.05). The VAS score in the observation group was significantly lower than the control group [(2.43 ±0.25) vs.(4.02 ±0.41)](P<0.05).The levels of gastrin and motilin in the observation group were significantly higher than the control group[ (55.87 ±4.82) pg/mL, (308.43 ±19.31) pg/mL vs. (44.12 ±3.86) pg/mL,(243.12 ±15.76) pg/mL](P<0.05).There was no significant difference in adverse reaction rate between two groups. Conclusion Mosapride citrate tablets can be used in gastroesophageal reflux disease , can effectively improve the patient's gastrin levels and clinical symptoms, clinical efficacy is good, and with low rate of adverse reactions.

关键词

枸橼酸莫沙必利片/胃食管反流病/胃泌素/疗效

Key words

mosapride citrate tablets/gastroesophageal reflux disease/gastrin/efficacy

引用本文复制引用

出版年

2017
中国生化药物杂志
南京生物化学制药研究所,全国生化制药情报中心站,中国生化制药工业协会,中国药品生物制品检定所

中国生化药物杂志

ISSN:1005-1678
被引量13
参考文献量7
段落导航相关论文